Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
New York, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today launched the nation’s largest St. Patrick’s Day fundraising campaign, MDA Shamrocks, as part of its ...
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new ...
A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the ...
Despite being almost completely paralysed, a South Korean student completed his master’s degree using eye-tracking technology.
Fifth Subject in BB-301 Phase 1b/2a Clinical Treatment Study safely treated in February 2025- -Interim clinical study update to be presented in late-breaking oral presentation at the 2025 Muscular ...
during an oral presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference being held March 16-19, 2025. Precision BioSciences, Inc. is a clinical stage gene ...
The T-shirt also celebrates the legacy, impact, and momentum of the Muscular Dystrophy Association during the organization's 75th anniversary. New York, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback